期刊文献+

三阴性乳腺癌中p53的表达及临床病理因子间的相关性 被引量:1

The Expression of p53 in TNBC and the Correlation among the Clinicopathological Factors
下载PDF
导出
摘要 目的探讨三阴性乳腺癌患者(TNBC)中p53的表达及与肿瘤大小(T分期)、淋巴结转移(N分期)、术后分期、年龄、月经状态间的关系。方法回顾性分析资料完整的40例TNBC与209例非三阴性乳腺癌(NTNBC)中p53的表达及TNBC中p53、T分期、N分期、术后分期、年龄、月经状态间的相关性。结果在TNBC中p53阳性表达率为65.0%,明显高于NTNBC的46.4%,差异显著,P值为0.038。在TNBC中,T分期与N分期、术后分期均呈正相关,相关系数分别为0.336、0.798,P值分别为0.034、0.000;N分期与月经状态呈负相关,相关系数为-0.368,P值为0.019;N分期与术后分期呈正相关,相关系数分别为0.730,P值为0.000;其余p53、T分期、N分期、术后分期、年龄、月经状态间无相关性。结论绝经前TNBC腋窝淋巴结转移风险增大。TNBC肿瘤越大,腋窝淋巴结转移越多,术后分期越晚,治疗效果不佳。TNBC中p53阳性表达增高,p53可以作为TNBC的治疗靶点。 Objective To explore the expression of p53 in triple-negative breast cancer (TNBC) and the correlation among the clinicopathologieal factors. Methods A retrospective study was made to the expressions of p53 in 40 cases with TNBC and 209 cases with non-triple-negative breast cancer (NTNBC); the correlation among the expression of p53, TNM, age and menstruation status in TNBC cases was analyzed. Results The positive expression of p53 in cases with TNBC was 65.0%, much higher than that in cases with NTN- BC, which was 46.4%, the difference was obvious (P=0.038); there existed a positive correlation between tumor size and axillary lymph node metastasis (r=0.336, P=0.034) and between tumor size and postoperative stage of TNM (r=0.798, P =0.000); axillary lymph node metastasis was in negative correlation with menstruation status (r=-0.368, P=0.019) while it was in positive correlation with postopera- tive stage of TNM (r=0.730, P=0.000); no correlation was observed among other factors. Conclusions The risk of TNBC axillary lymph mode metastasis is bigger before menopause; the bigger the size of TNBC t is, the heavier the axillary lymph node metastasis is; late postoperative stage of TNM leads to poor curative effect; the positive expression of p53 is high in TNBC, which may be taken as a target in the treatment of TNBC.
出处 《西南军医》 2015年第3期249-252,共4页 Journal of Military Surgeon in Southwest China
关键词 P53 三阴性 乳腺癌 临床病理因子 相关性 p53 triple-negative breast cancer clinicopathological factor correlation
  • 相关文献

参考文献15

  • 1Siegel R, Ma J, Zou Z, et al. Cancer statistic, 2014 [J]. CA: Cancer J Clin, 2014,64( 1 ):9-29.
  • 2Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in Chi- na[J]. Lancet Oncol, 2014, 15(7):279-289.
  • 3Sorlie T, Perou CM, Yibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications [J]. Proc Nail Acad Sci USA, 2001, 98( 19):10869-10874.
  • 4Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: high- lights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 [J]. An- nals of Oncology, 2013, 24 (9) :2206-2223.
  • 5Rakha EA, E1-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer[J]. Cancer, 2007, 109(1 ):25-32.
  • 6Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor.(PR)-negative, and HER2-negative invasive breast can- cer, the so-called triple-negative phenotype: a popula- tion-based study from the California cancer Registry [J]. Cancer, 2007,109(9):1721-1728.
  • 7Semiglazov V, Eiermann W, Zambetti M, et al. Surgery fol- lowing neoadjuvant therapy in patients with HER2-posi- tive locally advanced or inflammatory breast cancer partic- ipating in the NeOAdjuvant Herceptin (NOAH) study [J]. Eur J Surg Oncol, 2011, 37( 10):856-863.
  • 8张慧明,宣立学,高纪东,张保宁,赵平.三阴性乳腺癌和非三阴性乳腺癌临床特征的比较[J].中华外科杂志,2009,47(7):506-510. 被引量:23
  • 9Han JS, Cao D, Molberg KH, et al. Hormone receptor sta- tus rather than HER2 status is significantly associated with increased Ki-67 and p53 expression in triple-negative breast carcinomas, and high expression of Ki-67 but not p53 is significantly associated with axillary nodal metasta- sis in triple-negative and high-grade non-triple-negative breast carcinomas [J]. Am J Clin Pathol, 2011, 135 (2): 230-237.
  • 10Dookeran KA, Dignam JJ, Ferrer K, et al. p53 as a marker of prognosis in African-American women with breast can- cer[J]. Ann Surg Oncol, 2010, 17(5): 1398-1405.

二级参考文献10

  • 1Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature, 2000, 406 : 747-752.
  • 2Kreike B, van Kouwenhove M, Horlings H, et al. Gene expression profiling and histopathological characterization of triple- negative/basal-like breast carcinomas. Breast Cancer Res, 2007, 9 : 404-405.
  • 3Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13: 4429-4434.
  • 4Bauer KR, Brown M, Cress RD, et al. Descriptive Analysis of Estrogen Receptor (ER) -Negative, Progesterone Receptor (PR) - Negative, and HER2-Negative Invasive Breast Cancer, the Socalled Triple-Negative Phenotype. Cancer, 2007, 109: 1721-1728.
  • 5Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109 : 25-32.
  • 6Carey LA, Perou CM, livasy CA, et al. Race, breast cancer subtype, and survival in the Carolina Breast Cancer Study. JAMA, 2006, 295:2492-2502.
  • 7Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature, 2005,436:518-524.
  • 8Rodriguez-Pinilla SM, Sarrio D, Honrado E, et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res, 2006, 12: 1533-1539.
  • 9Bidard FC, Conforti R, Boulet T, et al. Does triple-negative phenotype accurately identify basal-like tumor? An immunohistochemical analysis based on 143 triple-negative breast cancers. Ann Oncol, 2007, 18:1285-1286.
  • 10袁中玉,王树森,朱美琴,郑磊,罗文标,周中梅,管忠震.不同分子亚型乳腺癌的临床特征和预后[J].中华肿瘤杂志,2008,30(6):456-461. 被引量:55

共引文献22

同被引文献27

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部